- Home
- NEO vs WLTH Comparison
NEO vs WLTH Comparison
Compare NEO & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEO | WLTH |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2008 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NEO | WLTH |
|---|---|---|
| Price | $16.54 | $10.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $21.85 | $12.25 |
| AVG Volume (30 Days) | 2.3M | ★ 3.1M |
| Earning Date | 10-28-2026 | 09-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $364,993,000.00 |
| Revenue This Year | $10.71 | $2.47 |
| Revenue Next Year | $9.96 | $16.60 |
| P/E Ratio | ★ N/A | $62.17 |
| Revenue Growth | N/A | ★ 18.17 |
| 52 Week Low | $7.07 | $7.20 |
| 52 Week High | $20.15 | $14.12 |
Technical Indicators
Market Signals| Indicator | NEO | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 53.54 |
| Support Level | $15.57 | $8.72 |
| Resistance Level | $16.92 | $11.18 |
| Average True Range (ATR) | 0.98 | 0.49 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 23.00 | 55.33 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About WLTH Wealthfront Corporation Common Stock
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.